Repeat prescriptions for common antibiotics could be banned in a move by the Pharmaceutical Benefits Advisory Committee.

The move is aimed at reducing the spread of superbugs and ensuring more responsible use of antibiotics.

AMA President, Tony Bartone, says ‘the things that we’ve used in the past become useless and the superbugs become exactly that, resistant to the effects of antibiotics which have been lifesaving for many, many decades.’